News
News
2024.04.08Dx&Vx Challenges Development of Injection-type Obesity Treatment as a Drug 2024.04.02Dx&Vx to launch personalized health functional food business 2024.03.12DXVX " Chinese subsidiary Targets KRW 38 Billion in Sales This Year... Continues Quan... 2024.03.04Dx&Vx will grow into a specialized think tank directly supporting medical reform 2024.02.26Dx&Vx Expands China's Pharmaceutical Product Line... Oral Inflammation Treatment Laun... 2024.02.14Achievement of the major milestone of Dx&Vx 'OVM-200' anticancer vaccine 2024.01.23Coree Group Commercializes Breast Milk Oligosaccharide Replacement… Dx&Vx Secures Co... 2024.01.16Dx&Vx held discussions on building partnerships with global pharmaceutical and biotech compani... 2024.01.02DXVX Launches 'Genetic Data' Service... 440,000 DBs 2023.12.26Dx&Vx will participate in the JP Morgan Conference•Biotech Showcase 2023.12.20DXVX Receives Presidential Award of Korea International Trade Association, a model expor... 2023.12.18Dx&Vx collaborates with LG CNS and Google Cloud to develop a medical data platform 2023.12.06Dx&Vx, Awarded ‘Top in $7 Million Exports’ on Trade Day 2023.12.05Dx&Vx Leaps To AI-Based New Drug Development Company 2023.11.24Dx&Vx and DT&CRO develop a companion diagnostic service 2023.11.22Dx&Vx promotes development of its own anti-cancer vaccine OVM-200 for treatment 2023.11.10DXVX "Demand for antibiotics skyrockets due to the spread of pneumonia in China... Sales w... 2023.11.01Kwon Kyu-chan, CEO of DXVX"Anticancer Vaccine, a UK subsidiary, launches Phase 1b wi... 2023.10.30Dx&Vx Introduces Azithromycin Antibiotics at Congress of Chinese Pediatric Society 2023.10.25Dx&Vx participates in 'CPhI Barcelona 2023' Discussing Global Partnerships 2023.10.23Dx&Vx, China's pharmaceutical distribution business is progressing smoothly 2023.10.10Dx&Vx Focusing on Drug Development Aims to Expand Global Business Operations 2023.10.08Hanmi Pharm Promises New Treatment for Patients with Extremely Rare Disease 2023.09.25Dx&Vx Signs $2.2 Million Contract to Export Microbiome Products to the EU 2023.09.18Dx&Vx Launches Integrated Companion Diagnostic Service 2023.09.13Dv&Vx and Genscript Sign MOU on Development of New Antibody Drug 2023.09.07Dx&Vx Expects to Receive Benefits from Ministry of Welfare as “Key Business Areas Inclu... 2023.09.06DxVx announces its ambitious plans for new drug development, targeting clinical trials within ... 2023.08.14DxVx records 14.1 billion won in the second quarter, 98% increase from the previous year 2023.08.01DxVx signs contract for vaccine delivery material and lipid nanoparticle process development 2023.07.24DxVx Unveils Global Launch of "Formulamate–Ofmom": A Probiotic for Infant Health 2023.07.19Dx&Vx Azithromycin Antibiotic Product Wins Gold Prize for Package Design at London Des... 2023.07.18DxVx sells antibiotics in the Chinese pharmaceutical market with Coree Group 2023.07.04DxVx spurs efforts to commercialize maternal and infant health, advancing total healthcare solu... 2023.06.26DxVx Convenes Meeting on ‘The Future of Korean Bio Industry’ 2023.06.19DxVx Hosts R&D Workshop “Growing as a New Drug Development Company” 2023.06.12Han Sung-jun, CEO of Avixgen, Promises “Seamless IPO by Making R&D Achievements w... 2023.06.09DxVx conducts the National Project of technology development of adult disease diagnosis sensors 2023.06.01DxVx propels technology transfer of two types of microbial strains 2023.05.23Avixgen: The R&D of High-quality Pipelines 2023.04.27Coree Beijing Wins Gold Prize for Yijiayi B420 Probiotics Package Design at the 2023 Germ... 2023.04.25COREE Pohang Temporarily Granted Approval for DX24 under the Regulatory Sandbox 2023.04.25DxVx Plans to Release 12 Microbiome-Based Health Supplements Globally 2023.04.21DxVx Enters Chinese Market with the Launch of Antibiotics Product 2023.04.07DxVx acquires Avixgen, a novel drug development platform company 2023.04.06DxVx deliberates on transferring microbiome-based pipeline technologies 2023.03.30DxVx’s affiliate, Oxford Vacmedix completed Phase 1a trial of novel cancer vaccine OVM-20... 2023.03.15Coree Pohang Launches the How to Care App for Wound Care 2023.03.02DxVx expects to reach another record high this year through all-in-one healthcare solutions 2023.02.13DxVx, led by Lim Chong-Yoon, Leaps Forward with Commercialization of Probiotics 2023.02.09DxVx Records 331% Rise in 2022 Sales and Turns to Surpluses 2023.01.11Ofmom Launches SynterAct Probiotics Drops to Support Baby's Intestinal Health 2023.01.05COREE Beijing Acknowledged for Outstanding Product Designs with the GDA and Good De... 2023.01.03Life Ofmom Builds a Healthy Maternal & Child Health Ecosystem 2023.01.03COREE Leading Digital Smart Healthcare with SCSS Smart Clinic System 2022.12.30Dx&Vx signs 3 billion-won precision medical genome analysis contract 2022.12.05Dx&Vx Won the “300 Mil Export Tower” Award 2022.11.15Dx&Vx Records Revenue of KRW 21.7 billion in Q3 2022.11.14Coree Pohang, an Affiliate of Coree Group, Enters Pohang Convergence Technology Industrial ... 2022.11.09Dx&Vx’s entry to Chinese market is expecting to create synergy with Coree 2022.11.02Lee Suwon, Director of Dx&Vx Microbiome R&D Center, “Microbiome business will go be... 2022.10.24Dx&Vx starts developing microbiome-based diabetes, obesity treatments 2022.10.12Korea Biopharm accelerates business diversification with the official launch of microbiome pro... 2022.09.22Lim Chong-Yoon reinforces its initiative through corporate acquisitions and investments 2022.09.16Dx&Vx acquires Korea Biopharm for 15 billion won…‘Enter the CDMO market’ 2022.09.08Dx&Vx raises 17.8 billion investment..."Reinvestment in the future value" 2022.08.24Dx&Vx Signs Agreement with Jointown to Supply In Vitro Diagnostic Medical Devices to C... 2022.08.17Dx&Vx Projected to Record All-Time High Earnings This Year with KRW 13 Billion in S... 2022.07.27Oxford Vacmedix announces filing of new patent for Anti-Microbial Resistance diagnostic test 2022.07.05Dx&Vx Markets Philips UV-C Disinfection Air Cleaner and Enters Disease Prevention Mar... 2022.06.09Hanmi Pharm Records Twenty Orphan Drug Designations Among First-in-Class Drugs Under... 2022.06.02Hanmi Expands Lineup of New Antihypertensive Drugs Based on Approval of Closartan 2022.05.27Life Ofmom APP Won the Double at 2022 Indigo Design Award 2022.05.20Orga Kiddy Won the Bronze Prize at the 2022 Indigo Design Award 2022.05.17Ofmom Brand Book Won the Gold Prize at the 2022 Indigo Design Award 2022.05.10New vaccine to treat cancer is now being trialled in Britons with prostate, lung and ovarian tu... 2022.05.10Lim Chong-Yoon, the Chief Director of Korea Bio Association, “New Government Should S... 2022.05.01A Call for Creation of Industry-University-Research-Government New Drug Development Clu... 2022.04.13Global Vaccine Hub「KHUB Science Park」Full-scale Promotion in Pohang City 2022.04.04Pohang Poised to Emerge as Global Vaccine Hub 2022.03.30KHUB Vaccine Consortium Headed by Chong-Yoon Lim to Be Launched as KHUB Science P... 2022.03.02The Eldest Son of the Hanmi Founder Pursues Cancer Vaccine Technology Which May Potenti... 2022.02.18Hanmi Pharm’s LAPSGlucagon, New Drug for Rare Diseases, Featured on the Cover of S... 2022.02.11FDA Approves NDA for Poziotinib from Hanmi Pharm and Begins Official Review 2022.01.20Hanmi Pharm Set to Produce COVID-19 Treatment for Merck and Supply to Developing Cou... 2022.01.13Hanmi Using Proprietary mRNA Platform to Develop New Drugs for Refractory Cancer and... 2022.01.11Hanmi Pharm Set to Produce DNA-based COVID-19 Vaccine Developed by Zydus Cadila 2021.12.17Hanmi Pharm Chairwoman Song Young-sook Selects Three Proud Members of Hanmi 2021.12.17Hanmi Pharm Honored with the Presidential Award at the Korea Brand Awards 2021.12.17Hanmi Pharm’s New Drug for Liver Disease Receives Orphan Drug Designation in Europe 2021.12.08Hanmi Pharm’s Study on New Drug for Diabetes Chosen as Late Breaker by AHA 2021.12.08Hanmi Pharm Presents Results of Follow-up Study to Phase 3 Clinical Trial on Efpeglenat... 2021.12.06Hanmi Pharm Set to “Announce a Joint Development Plan with a Global LNP Company T... 2021.11.18Ofmom Korea Signs Sponsorship Agreement for Atopy Patients 2021.11.18Hanmi Pharm Presents Phase 2 Clinical Study on CCR4-Targeting Anticancer Agent 2021.11.18COREE partners with Infini Fluidics to develop new mRNA vaccine-making method 2021.11.08Hanmi Pharm’s First-in-Class Drug for Rare Disease Selected for National New Drug De... 2021.11.05Hanmi Pharmaceutical Ranks No. 1 in Sustainability Management in Pharmaceutical Industry ... 2021.11.04Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi... 2021.10.28Hanmi Science Joins Forces with AstraZeneca Team at Oxford to Prepare Against Future P... 2021.10.28Hanmi Science Signs Agreement with University of Oxford for Pandemic Science Alliance ... 2021.10.25Lim Chong-yoon, CEO of Hanmi Science, Appointed as Director of Cancer ROP 2021.10.21CancerRop Concludes Immune Cell Profiling Research Agreement to Build Big Data for Vac... 2021.10.19The Lancet Publishes Paper on New Biologic Developed by Hanmi 2021.10.12Joint Marketing Campaign for Probiotic Supplement, SynterAct, and Postpartum Care Cente... 2021.08.17Lim Sung-ki, the founder, chairman and CEO of Hanmi Pharmaceutical Group, dreams of ma... 2021.08.10Hanmi Pharmaceutical is taking steps to develop an mRNA coronavirus vaccine… “If it is dev... 2021.08.05Mamiai from Bejing Hanmi Pharmaceutical Wins over Countless Mothers in China 2021.07.23Hanmi Pharmaceutical Group and Lego Chem Bio Partner up to Jointly Develop ADC for C... 2021.07.06Hanmi Pharmaceutical Vying for the Position of “Vaccine Hub” 2021.07.01KNIH Verifies Hanmi Fine Chemical’s mRNA Technology 2021.07.01Korea National Institute of Health (KNIH) conducts field inspection of companies with mRN... 2021.06.16President Lim Chong-yoon of Hanmi Science, “It’s possible to swiftly supply mRNA vacci... 2021.06.07New Cancer Drug from Hanmi Pharmaceutical Garners Attention at ASCO 2021 2021.05.31Hanmi Science and GeneOne Life Science Build Infrastructure for Mass Production of mRNA... 2021.05.18Hanmi Pharmaceutical Set to Manufacture COVID-19 Vaccine Developed by Genexine 2021.05.12Hanmi Pharmaceutical’s New Biologic Receives Another Orphan Drug Designation from US... 2021.04.12Hanmi Sees the Potential of Digital Therapeutics Developer, Herings 2021.04.02Peking Union Medical College Hospital held an opening meeting for exploratory research project... 2021.01.25Hanmi Pharmaceutical’s Milestones in the Pharmaceutical Industry 2021.01.19Hanmi Set to Release Quick COVID-19 Test Kit 2021.01.13Hanmi’s Special Task Force Set to Develop Digital Therapy for COVID-19 2021.01.07COVID-19 Vaccines Differing in Mechanism and Characteristics 2020.12.23K-Bio Speeds up Development of Green Vaccine for COVID-19 2020.12.031 Billion Doses a Year… It Will Become an Outpost for the Consigned Production of a Coron... 2020.10.17LIFE OFMOM APP from OFMOM Won the ‘2020 Good Design Award’ 2020.10.16Hanmi Pharm has been Selected as the No. 1 Company for ‘Corporate Sustainability Managem... 2020.09.28Hanmi Science “Heavy responsibility…Devote to trust management based on morality” 2020.09.17Syntekabio-Hanmi Science, Develop ‘Inhalation-type Treatment for COVID-19’ 2020.08.05Hanmi Pharm’s LAPSGLP/GCG Technology Export Has Created "Three birds with one s... 2020.08.04Hanmi Pharm’s New Drug Substance Returned by Janssen Has Exported 1 Trillion Won of T... 2020.07.30Hanmi Science and Theragen Sign MOU for Joint Development of Genetic Analysis Method 2020.07.29Hanmi Science, Laying the Cornerstone for the Six Visions through Medical Science Center 2020.07.13Hanmi Science- Bioapp “Green bio-based COVID-19 vaccine on full-scale development” 2020.06.29Celltrion•Samsung Biologics•Hanmi Science•Samsung Pharmaceutical speed up for the bio ... 2020.06.18CEO Chong-Yoon Lim will lead ‘Post COVID-19’ in Hanmi Pharmaceutical Group 2020.06.17Hanmi Science Launch innovative ‘Green Bio’ drug development platform and manufacturing s... 2020.06.17Hanmi Science Oral Vaccine Platform to give a next generation Orascovery science 2020.06.15Hanmi Science Set Up A "Smart Healthcare" Complex in Pohang, Gyeongsangbuk-do 2020.06.15Hanmi Science Presents 6 Great Visions for Post COVID-19 2020.04.21Chaer Dairy Received Two Subsidies from Government 2019.12.18Chongyoon Lim's Representative Departed to China and Italy to Unveil the "Second Act" of H... 2019.12.06"Medi Jointown to Prosperity, Care China to Health", A Successful Cooperation between Jo... 2019.11.25Hanmi Science and Pohang University of Science and Technology (North Gyeongsang, South Ko... 2019.11.19COREE Group, an Affiliate of Hanmi Science, "Promotes FDA Approval of One-to-One C... 2019.11.15COREE Group and Peking Union Medical Foundation Establish Metabolic Diseases Preventio... 2019.11.04[Asian Invitation Seat] "South Korean biological medicine is mixed with both joy and sorrow ... 2019.03.01Chongyoon-Lim, the CEO of Hanmi Science Creating "Dong-Ui-Bo-Gam" of Bio-Bank. 2019.02.13Chongyoon Lim, new Chairman of Korean Biological Association, said he would strive to buil... 2019.02.11SandBox genetic analysis has been expanded to 25 types, and the market scale has been expanded co... 2019.02.11Chairman Chongyoon-Lim: Time to Bring the Power of South Korea Biology into Play 2019.02.11In order to ensure a fair and just enterprise, listed subsidiaries of Hanmi Pharm. set up Board... 2018.12.12In Rome, the first International Symposium on the care of mother and child 2018.11.02The first Ofmom Centre for postpartum care of mothers and newborns is opening in Rome, Ita... 2018.06.13Hanmi Science Set Up a Maternal and Infant Biobank in Rome 2018.04.12Public Health: The “Mothers’ Road” Joins “Belt and Road” 2018.04.12Chongyoon-Lim, the representative of Hanmi Science, concluded and entered into the Agreement... 2018.04.12Create the milk powder for the world with the mothers' sincerity and love 2018.04.12Hanmi Pharm. Co., Ltd.--Sungki-Lim&Chongyoon-Lim Signed and Concluded the Public Me... 2018.04.12MAMIAIWas Selected in the 2016 Most Internet Influential Drug Brand List 2018.04.12MAMIAI Won the Top 10 Brand Construction Awards of the 10th "Healthy China 2030 Brand P... 2018.04.12MAMIAI Took the First Place in Gastrointestinal Drug Brand List of "Tmall Pharmacy" 2018.04.12Analysis on Market Share of Domestic Pediatric Gastrointestinal Drugs in the First Half of... 2017.12.03Public Health: The “Mothers’ Road” Joins “Belt and Road” 2017.10.28"YUN·YU" -- CENTRE OFMOM invites you to talk with your baby for the first time 2017.10.23Create the milk powder for the world with the mothers' sincerity and love Ofmom Company i... 2017.10.05Chongyoon-Lim, the representative of Hanmi Science, concluded and entered into the Agreement... 2017.08.01Ofmom leads the new cultural trend of feeding by releasing infant formula liquid mil... 2016.11.23Ofmom Won Laurel of 2016 Sina Baby Annual “Trusted Intestinal Health Brand of Chinese M... 2016.11.20Ofmom Antenatal Training Concert Comes again Warmly to Play Pregnant Love Melody 2016.07.01Ofmom “Growth Caring Tour” Walks into Luoyang Children Welfare Home